Stay updated on Mepolizumab SC 100mg in Severe Eosinophilic Asthma Clinical Trial
Sign up to get notified when there's something new on the Mepolizumab SC 100mg in Severe Eosinophilic Asthma Clinical Trial page.
Latest updates to the Mepolizumab SC 100mg in Severe Eosinophilic Asthma Clinical Trial page
- Check3 days agoChange DetectedThe type of intervention has been updated from version v2.13.3 to v2.14.0.SummaryDifference0.2%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedThe latest update includes detailed results on serious and non-serious adverse events, clinically significant asthma exacerbations, and changes in lung function and asthma control metrics at Week 24, reflecting a comprehensive assessment of participant outcomes in the study.SummaryDifference29%
- Check39 days agoChange DetectedThe website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.SummaryDifference2%
- Check53 days agoChange DetectedThe website has added a 'Show less' feature, while several detailed data fields and options related to participant groups, interventions, and study details have been removed.SummaryDifference3%
- Check68 days agoChange DetectedThe website has been updated to version v2.12.2, adding new features for downloading study data in various formats and displaying detailed participant and study information, while removing the 'Show less' option and the previous version v2.12.1.SummaryDifference3%
- Check75 days agoChange DetectedThe website has updated to version v2.12.1, introducing 'Results Submitted' while removing 'No Results Posted' from the previous version v2.12.0.SummaryDifference0.2%
Stay in the know with updates to Mepolizumab SC 100mg in Severe Eosinophilic Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mepolizumab SC 100mg in Severe Eosinophilic Asthma Clinical Trial page.